Skip to main content
Nexphoria
CJC-1295 5mg

NEXPHORIA

CJC-1295

GHRH analog with DAC. Extended half-life growth hormone releasing peptide.

For Research Use Only
$46.00per vial

Purchase Type

Fresh cold-chain delivery every 30 days

Size

Format

≥98.5%
HPLC Verified
Cold-Chain
For Research Use Only

For Research Use Only — Not For Human Consumption

This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.

CJC-1295 is a tetrasubstituted GHRH(1-29) analog featuring a Drug Affinity Complex (DAC) modification — a maleimidoproprionic acid linker that enables covalent bonding to endogenous albumin Cys-34. This single modification extends plasma half-life from approximately 7 minutes (native GHRH) to 6–8 days, enabling sustained somatotropic axis stimulation with infrequent dosing.

Side-by-Side Analysis

Compare CJC-1295 with Similar Compounds

View purity, MW, storage, and pricing side by side.

Frequently Bought Together

Complete Your Protocol

Researchers commonly order these compounds together. Convenient multi-compound ordering.

CJC-1295

Growth Hormone

This item

CJC-1295

5mg

$46

Ipamorelin

Growth Hormone

Recommended

Ipamorelin

10mg

$54

CJC-1295 / Ipamorelin

Growth Hormone

CJC-1295 / Ipamorelin

10mg

$66

CJC-1295IpamorelinCJC-1295 / Ipamorelin

3 items selected

$166

Uncheck any item to customize your bundle. Discount applied automatically at checkout.

Complete Your Protocol

Pulsatile GH Stack

CJC-1295 without DAC has a shorter half-life ideal for pulsatile dosing alongside Ipamorelin for a physiological GH secretion pattern.

CJC-1295
Current

Growth Hormone

CJC-1295

5mg

$46

+
stack
Ipamorelin

Growth Hormone

Ipamorelin

10mg

$54

$100
View Ipamorelin

RUOFor Research Use Only (RUO) — Not for human consumption, clinical use, diagnostic use, or veterinary applications.